Abstract
Two children who developed acute renal failure in the immediate post-renal transplantation period are presented. Each was immunosuppressed with cyclosporin and was also receiving oral acyclovir for prophylaxis against cytomegalovirus infection. Renal biopsy findings suggested drug toxicity. Discontinuation of acyclovir coincided with reversal of renal impairment. As cyclosporin levels were at the lower end of the therapeutic range, we believe acyclovir to be the likely causative agent.
This is a preview of subscription content, log in via an institution to check access.
References
Belfour HH, Chase BA, Stapleton JT, Simmons RL, Fryd DS (1989) A randomised, placebo controlled trial of acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320: 1381–1387
Snydman DR, Werner BG, Heinz-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL Jr, Levey AS, Strom TB, Carpenter CB, Levey RH, Harmon WE, Zimmerman CE, Shapero ME, Steinman T, Logerfo F, Idelson B, Scroter G, Levin MJ, McIver J, Lesczynski J, Grady GF (1987) Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal transplant recipients. N Engl J Med 317: 1049–1054
Sawyer MH, Webb EW, balow EJ, Straus SE (1988) Acyclovir induced renal failure. Am J Med 84: 1067–1071
Rashed A, Azadeh B, Abu Romeh SH (1990) Acyclovir-induced acute tubulo-interstitial nephritis. Nephron 56: 436–438
Dugandzic RM, Sketris IS, Beltsky P, Schlech WE, Givner ML (1991) Effect of coadministration of acyclovir and cyclosporin on kidney function and cyclosporin concentration in renal transplant patients. DICP 25: 316–317
Shulman H, Striker G, Deeg HJ, Kennedy M, Storb R, Thomas ED (1981) Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thrombosis and tubular injury. N Engl J Med 305: 1392–1395
Brigden D, Rosling AE, Woods NC (1982) Renal function after acyclovir intravenous injections. Acyclovir symposium. Am J Med 73 [Suppl 1A]: 182–185
Stoffel M, Squifflet JP, Pirson Y, Lamy M, Alexander GPJ (1987) Effectiveness of oral acyclovir prophylaxis in renal transplant recipients. Transplant Proc 19: 2190–2193
Johnson PC, Kumar K, Welsh MS, Woo J, Kahan BD (1987) Effects of coadministration of cyciosporin and acyclovir on renal function of renal allograft recipients. Transplantation 44: 329–331
Shepp DH, Dandliker PS, Meyers JD (1986) Treatment of varicella-zoster virus infection in severely immunocompromised patients; a randomised comparison of acyclovir and vidarabine. N Engl J Med 314: 208–212
Brayman KL, Dafoe DC, Smythe WR, Barker CF, Perloff LJ, Naji A, Fox IJ, Grossman RA, Jorgasky DK, Starr SE, Freidman HM, Plotkin SA (1988) Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial. Arch Surg 123: 1502–1508
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ahmad, T., Simmonds, M., McIver, A.G. et al. Reversible renal failure in renal transplant patients receiving oral acyclovir prophylaxis. Pediatr Nephrol 8, 489–491 (1994). https://doi.org/10.1007/BF00856544
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00856544